- Home
- DERM vs OPP Comparison
DERM vs OPP Comparison
Compare DERM & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.73
Company Overview
Basic Information| Metric | DERM | OPP |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 198.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DERM | OPP |
|---|---|---|
| Price | $8.73 | $7.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 143.6K | 108.0K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,399,000.00 | N/A |
| Revenue This Year | $17.48 | N/A |
| Revenue Next Year | $55.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $3.63 | $7.26 |
| 52 Week High | $9.56 | $8.83 |
Technical Indicators
Market Signals| Indicator | DERM | OPP |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 44.61 |
| Support Level | $7.66 | $7.78 |
| Resistance Level | $9.00 | $8.01 |
| Average True Range (ATR) | 0.55 | 0.07 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 69.63 | 32.61 |
Price Performance
Historical Comparison DERM
OPP
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.